See prescribing information, including boxed warning Austedo is used to treat the involuntary movements of huntington's disease and tardive dyskinesia (td) Includes austedo side effects, dosage, uses, interactions, and more New phase 4 data reveals austedo significantly reduces involuntary movements and enhances quality of life for adults with tardive dyskinesia. Tardive dyskinesia (td) is a disorder that can cause repetitive movements such as twitching, shaking, or jerking in the arms, legs, face (including eyes and mouth), and torso The findings were presented at the 2025 neuroscience education institute.
Affiliate of teva pharmaceutical industries ltd Austedo, with the generic name deutetrabenazine, is a medication specifically designed for managing movement disorders such as chorea associated with huntington's disease and tardive dyskinesia Many individuals facing these disorders often seek information on treatment options that can improve their quality of life This article aims to demystify austedo treatment by exploring its mechanism.
WATCH
